ObsEva

Last update: 19 days ago

Biotechnology
Switzerland Its 16 main executives

Recent executive movements at ObsEva

Fabien de Ladonchamps who is Vice President, Corporate Affairs and Finance, will become Interim Chief Financial Officer and Member of the Executive Committee on Apr. 10, 2020  (news posted on April 6 2020).
Timothy Adams, Chief Financial Officer, will leave the company on Apr. 10, 2020  (news posted on April 6 2020).

Create an alert
to follow the executive moves at ObsEva.

Latest M&A news in Biotechnology.

Alexion Pharmaceuticals has acquired Portola Pharmaceuticals (posted on Jul 2, 2020).
Pionyr Immunotherapeutics and Gilead Sciences have announced they will merge (posted on Jun 23, 2020).
Invitae has announced the acquisition of Archerdxinc (posted on Jun 23, 2020).

The most constantly updated executive directory.

Companies

Companies

Learn about your clients' org charts. Understand their industries and their competitors.

Executives

Executives

View the executives' biographies. Contact the executives through our email platform.

Alerts

Alerts

Select key words to follow your clients. Receive alerts when executive movements happen.

Customers

Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.